Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0LR0R
|
||||
| Former ID |
DAP001070
|
||||
| Drug Name |
Methdilazine
|
||||
| Synonyms |
Disyncram; Methdilazinum; Methodilazine; Metodilazina; Tacaryl; Tacazyl; Tacryl; Methilazine hydrochloride; Methdilazine (INN); Methdilazinum [INN-Latin]; Metodilazina [INN-Spanish]; Tacaryl (TN); Methdilazine [USAN:INN:BAN]; 10-((1-Methyl-3-pyrrolidinyl)methyl)phenothiazine; 10-((1-methyl-3-pyrrolidinyl)methyl)-10H-phenothiazine; 10-[(1-Methylpyrrolidin-3-yl)methyl]phenothiazine; 10-[(1-methylpyrrolidin-3-yl)methyl]-10H-phenothiazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Approved | [1], [2] | ||
| Therapeutic Class |
Antihistamines
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H20N2S
|
||||
| InChI |
InChI=1S/C18H20N2S/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20/h2-9,14H,10-13H2,1H3
|
||||
| InChIKey |
HTMIBDQKFHUPSX-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 1982-37-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9384, 135654, 647047, 7593023, 8161076, 10319677, 10512529, 11405746, 14751550, 29282717, 46505472, 47206710, 48035414, 48259508, 48416241, 49855141, 57328680, 79551326, 85209817, 103770942, 104335139, 117404375, 128111044, 131342044, 134338327, 134982817, 137101853, 141522707, 160964241, 176262319, 178103805, 179116778, 184528625, 223440310, 224019337, 226492957, 249964340
|
||||
| SuperDrug ATC ID |
R06AD04
|
||||
| SuperDrug CAS ID |
cas=001982372
|
||||
| Target and Pathway | |||||
| Target(s) | Histamine H1 receptor | Target Info | Antagonist | [3] | |
| KEGG Pathway | Calcium signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Inflammatory mediator regulation of TRP channels | |||||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| Reactome | Histamine receptors | ||||
| G alpha (q) signalling events | |||||
| WikiPathways | Monoamine GPCRs | ||||
| GPCRs, Class A Rhodopsin-like | |||||
| IL-4 Signaling Pathway | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7231). | ||||
| REF 2 | Drug information of Methdilazine, 2008. eduDrugs. | ||||
| REF 3 | Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice. Neuropharmacology. 1985 Jan;24(1):1-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.